1. A pharmaceutical composition characterized in that it comprises an activated - potentiated form of antibodies to bradykinin, activated - potentiated form of antibodies to morphine and activated - potentiated form of antibodies to gistaminu.2. A pharmaceutical composition according to claim 1, characterized in that an activated -. Potentiated form of antibodies to bradykinin, activated - potentiated form of antibodies to morphine and activated - potentiated form of antibodies to histamine used in the form of activated - potentiated aqueous or hydroalcoholic solution, which activity is due to serial dilutions process repeated in an aqueous or aqueous-alcoholic solvent in combination with an external mechanical action - by shaking each pa zvedeniya.3. A pharmaceutical composition according to claim 1, characterized in that the pharmaceutical composition is in solid dosage form and comprises an effective amount of saturated activated -. Potentiated form of antibodies to bradykinin activated - potentiated form of antibodies to morphine and activated - potentiated form of antibodies to histamine neutral carrier granules and pharmaceutically acceptable dobavki.4. A pharmaceutical composition according to claim 1, characterized in that the aqueous or aqueous-alcoholic solutions of the activated -. Potentiated forms of antibodies to bradykinin, morphine and histamine are obtained by repeated consecutive dilutions combined with external mechanical impact - shaking of each dilution of the matrix solution of antibodies to bradykinin, morphine and GIS1. Фармацевтическая композиция, характеризующаяся тем, что содержит активированную - потенцированную форму антител к брадикинину, активированную - потенцированную форму антител к морфину и активированную - потенцированную форму антител к гистамину.2. Фармацевтическая композиция по п. 1, характеризующаяся тем, что активированную - потенцированную форму антител к брадикинину, активированную - потенцированную форму антител к морфину
